The Question of Maintenance Therapy: For Whom and How Long?

Recorded on September 21st, 2021 as part of the Relapsed/Refractory Myeloma Chapter in the Myeloma Crowd Community by HealthTree Program with Multiple Myeloma Specialist Dr. Ghulam Mohyuddin. The Myeloma Crowd brings information from the experts to the patients! Learn more at https://www.myelomacrowd.org/ HealthTree Cure Hub helps you find your best treatment options and accelerate a cure for multiple myeloma. Join today at https://www.healthtree.org/

Learn About Personalized Resources to Support Your Care Journey with the Janssen Compass Program
▶︎

Learn About Personalized Resources to Support Your Care Journey with the Janssen Compass Program

Setting Up Your Expectations For Having Myeloma
▶︎

Setting Up Your Expectations For Having Myeloma

Game-Changing Therapy in Relapsed and Refractory Myeloma | Ajay Nooka, MD #myeloma
▶︎

Game-Changing Therapy in Relapsed and Refractory Myeloma | Ajay Nooka, MD #myeloma

"La guerra di Trump? Nelle nostre tasche: tra riarmo e finanza siamo il bancomat di Wall Street"
▶︎

"La guerra di Trump? Nelle nostre tasche: tra riarmo e finanza siamo il bancomat di Wall Street"

The Most Famous (TV) Doctor Of All Time | Noah Wyle
▶︎

The Most Famous (TV) Doctor Of All Time | Noah Wyle

The Lenalidomide Patch for Myeloma: What Do We Know?
▶︎

The Lenalidomide Patch for Myeloma: What Do We Know?

028 Myeloma in 2026 - What's Coming Next and Why It Matters
▶︎

028 Myeloma in 2026 - What's Coming Next and Why It Matters

But what is quantum computing?  (Grover's Algorithm)
▶︎

But what is quantum computing? (Grover's Algorithm)

AI Is Creating A Rare Opportunity For Investors. How Jim Roppel Is Playing It. | Investing With IBD
▶︎

AI Is Creating A Rare Opportunity For Investors. How Jim Roppel Is Playing It. | Investing With IBD

Using Daratumumab to Treat High-Risk Myeloma Patients
▶︎

Using Daratumumab to Treat High-Risk Myeloma Patients

Learn more about THYROID RFA: Dr. Jules Aljammal - #80
▶︎

Learn more about THYROID RFA: Dr. Jules Aljammal - #80

How Personalized Is Myeloma Treatment and How Is Changing? Introducing the Individual Risk Model
▶︎

How Personalized Is Myeloma Treatment and How Is Changing? Introducing the Individual Risk Model

LRR Microbiology for FMGE 2026 By Dr. Preeti Sharma
▶︎

LRR Microbiology for FMGE 2026 By Dr. Preeti Sharma

RSV Hospitalization Prevention  Infant vs Maternal Strategies | VAC4EU Journal Club
▶︎

RSV Hospitalization Prevention Infant vs Maternal Strategies | VAC4EU Journal Club

Optimizing the Selection of First-Line Therapy for Patients with Multiple Myeloma (Video Lecture)
▶︎

Optimizing the Selection of First-Line Therapy for Patients with Multiple Myeloma (Video Lecture)

Recognizing Post-Viral Syndromes & Tools for Management
▶︎

Recognizing Post-Viral Syndromes & Tools for Management

Your Multiple Myeloma Lab Results, Decoded: What They Mean and What They Don’t
▶︎

Your Multiple Myeloma Lab Results, Decoded: What They Mean and What They Don’t

AI 최후의 승자 이래서 구글입니다 (KAIST 전자및전기공학부 김정호 교수)
▶︎

AI 최후의 승자 이래서 구글입니다 (KAIST 전자및전기공학부 김정호 교수)

산책은 소용 없습니다. 숨차게 뛰어야 하는 과학적인 이유 (서울대 의대 재활의학교실 정세희 교수)
▶︎

산책은 소용 없습니다. 숨차게 뛰어야 하는 과학적인 이유 (서울대 의대 재활의학교실 정세희 교수)

Know Your Myeloma Therapy: REVLIMID with Dr. Craig Cole
▶︎

Know Your Myeloma Therapy: REVLIMID with Dr. Craig Cole